BR9612225A - Microgrânulos de liberação prolongada e cápsulas gelificadas - Google Patents

Microgrânulos de liberação prolongada e cápsulas gelificadas

Info

Publication number
BR9612225A
BR9612225A BR9612225A BR9612225A BR9612225A BR 9612225 A BR9612225 A BR 9612225A BR 9612225 A BR9612225 A BR 9612225A BR 9612225 A BR9612225 A BR 9612225A BR 9612225 A BR9612225 A BR 9612225A
Authority
BR
Brazil
Prior art keywords
extended
release microgranules
gelled capsules
gelled
capsules
Prior art date
Application number
BR9612225A
Other languages
English (en)
Inventor
Patrice Debregeas
Gerard Leduc
Pascal Oury
Pasal Suplie
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9485856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9612225(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of BR9612225A publication Critical patent/BR9612225A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR9612225A 1995-12-22 1996-12-23 Microgrânulos de liberação prolongada e cápsulas gelificadas BR9612225A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9515361A FR2742660B1 (fr) 1995-12-22 1995-12-22 Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
PCT/FR1996/002040 WO1997023219A1 (fr) 1995-12-22 1996-12-23 Microgranules a liberation prolongee contenant du diltiazem comme principe actif

Publications (1)

Publication Number Publication Date
BR9612225A true BR9612225A (pt) 1999-07-13

Family

ID=9485856

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9612225A BR9612225A (pt) 1995-12-22 1996-12-23 Microgrânulos de liberação prolongada e cápsulas gelificadas

Country Status (27)

Country Link
US (3) US6228395B1 (pt)
EP (1) EP0868184B1 (pt)
JP (1) JP2000506500A (pt)
KR (1) KR100354054B1 (pt)
CN (1) CN1145488C (pt)
AR (1) AR004410A1 (pt)
AT (1) ATE238798T1 (pt)
AU (1) AU721949B2 (pt)
BG (1) BG63770B1 (pt)
BR (1) BR9612225A (pt)
CA (1) CA2242224C (pt)
DE (1) DE69627880T2 (pt)
DK (1) DK0868184T3 (pt)
EA (1) EA001721B1 (pt)
EE (1) EE04045B1 (pt)
ES (1) ES2198505T3 (pt)
FR (1) FR2742660B1 (pt)
GE (1) GEP20022629B (pt)
HK (1) HK1018400A1 (pt)
HU (1) HU224214B1 (pt)
IL (1) IL125047A (pt)
NO (1) NO324680B1 (pt)
NZ (1) NZ324739A (pt)
PL (1) PL186621B1 (pt)
PT (1) PT868184E (pt)
WO (1) WO1997023219A1 (pt)
ZA (1) ZA9610776B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
FR2831546B1 (fr) * 2001-10-31 2007-03-23 Atofina Materiau polymere thermoplastique pour supports d'enregistrement d'informations audio et/ou optiques
BRPI0415242B8 (pt) * 2003-10-10 2021-05-25 Ethypharm Sa microgrânulos de liberação gradual contendo extrato de gingko biloba e o processo para fabricar estes
US20070122471A1 (en) * 2003-12-25 2007-05-31 Takeda Pharmaceutical Company Limited Method of improving suitability for granulation
JP2005306778A (ja) * 2004-04-21 2005-11-04 Basf Ag 徐放性製剤及びその製造方法
WO2006013431A1 (en) * 2004-07-29 2006-02-09 Pfizer Limited Stable controlled-release pharmaceutical formulation of eletriptan
US8778395B2 (en) * 2005-08-11 2014-07-15 Andrx Labs, Llc Diltiazem controlled release formulation and method of manufacture
KR20140079441A (ko) * 2006-06-19 2014-06-26 알파마 파머슈티컬스 엘엘씨 약제학적 조성물
ITFI20110172A1 (it) 2011-08-08 2013-02-09 Valpharma Sa Formulazione multiparticolata a rilascio modificato di diltiazem hcl.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
DK173505B1 (da) * 1987-02-20 2001-01-15 Pharmatec Internat S R L Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t
JPH07552B2 (ja) * 1987-11-06 1995-01-11 田辺製薬株式会社 持効性製剤
FR2623714B1 (fr) * 1987-11-26 1990-04-20 Ethypharm Sa Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
FR2630647B1 (fr) * 1988-04-27 1991-08-16 Sanofi Sa Microbilles de diltiazem, leur procede de fabrication et compositions pharmaceutiques a liberation prolongee les contenant
US5288505A (en) 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5229135A (en) * 1991-11-22 1993-07-20 Prographarm Laboratories Sustained release diltiazem formulation
US5376384A (en) 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif

Also Published As

Publication number Publication date
DE69627880D1 (de) 2003-06-05
JP2000506500A (ja) 2000-05-30
HUP9904129A3 (en) 2000-11-28
DK0868184T3 (da) 2003-08-25
FR2742660B1 (fr) 1998-04-03
ZA9610776B (en) 1997-06-30
HK1018400A1 (en) 1999-12-24
EP0868184A1 (fr) 1998-10-07
EP0868184B1 (fr) 2003-05-02
US20020182253A1 (en) 2002-12-05
EA199800593A1 (ru) 1998-12-24
CN1207681A (zh) 1999-02-10
KR100354054B1 (ko) 2003-02-14
BG102555A (en) 1999-02-26
ES2198505T3 (es) 2004-02-01
KR19990076717A (ko) 1999-10-15
PT868184E (pt) 2003-09-30
EE9800197A (et) 1998-12-15
NO982738L (no) 1998-08-21
NO982738D0 (no) 1998-06-12
PL327567A1 (en) 1998-12-21
GEP20022629B (en) 2002-02-25
FR2742660A1 (fr) 1997-06-27
US6383516B1 (en) 2002-05-07
WO1997023219A1 (fr) 1997-07-03
CA2242224A1 (fr) 1997-07-03
NO324680B1 (no) 2007-12-03
NZ324739A (en) 2000-01-28
US6228395B1 (en) 2001-05-08
AR004410A1 (es) 1998-11-04
IL125047A0 (en) 1999-01-26
CA2242224C (fr) 2004-01-13
CN1145488C (zh) 2004-04-14
DE69627880T2 (de) 2004-03-11
IL125047A (en) 2003-05-29
US6660296B2 (en) 2003-12-09
EE04045B1 (et) 2003-06-16
HU224214B1 (hu) 2005-06-28
EA001721B1 (ru) 2001-08-27
PL186621B1 (pl) 2004-02-27
BG63770B1 (bg) 2002-12-29
ATE238798T1 (de) 2003-05-15
HUP9904129A2 (hu) 2000-04-28
AU721949B2 (en) 2000-07-20
AU1198397A (en) 1997-07-17

Similar Documents

Publication Publication Date Title
DE69615461D1 (de) Verbinder und Abdeckung dafür
BR9508604A (pt) Fecho de cápsula e sapato
DE69631389D1 (de) Stopfen
BR9407178A (pt) Cápsula de gelatina
DE69606550D1 (de) Medizinischen verbindungsanordnung
DE69633193D1 (de) Anschlussbuchse
GB2298137B (en) Soft gelatin capsules
BR9612225A (pt) Microgrânulos de liberação prolongada e cápsulas gelificadas
NO980725D0 (no) Konnektor
DE69636841D1 (de) Entwicklungsgerät und Bilderzeugungsapparat
DE59609250D1 (de) Stimulationssystem
DE29512614U1 (de) Anschlußklemme
BR9606618A (pt) Conjunto de embalagem e carregador
FI964335A (fi) Kotelo
FR2742264B1 (fr) Connecteur perfectionne
DE29512786U1 (de) Anschlußstück
IL118629A (en) N-substituted CIS-N-propenyl-acetamides and their preparation
DE29514010U1 (de) Anschlußklemme
DE29502063U1 (de) Anschlußklemme
DE29508024U1 (de) Implantierbare Einrichtung
ITRM950248V0 (it) Prova e riprova
KR970006219A (ko) 셀화된 무기질 바디 및 이의 제조방법
KR970003365U (ko) 콘넥터
DE29516735U1 (de) Pfosten-Riegelverbinder
DE29504843U1 (de) Anschlußstück

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]